๎
๎ผ
๎
PolyPid Ltd
PYPD๎น
์์ธ ์ฐจํธ ๋ณด๊ธฐ
4.520USD
+0.170+3.91%
์ข
๊ฐย 02/06, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
75.19M์๊ฐ์ด์ก
์์คP/E TTM
๎
Intraday
1m
30m
1h
D
W
M
D
์ค๋
+3.91%
5์ผ
-1.31%
1๊ฐ์
-1.09%
6๊ฐ์
+38.65%
์ฌํด ํ์ฌ๊น์ง
+4.15%
1๋
+55.86%
์์ธ ์ฐจํธ ๋ณด๊ธฐ
TradingKey ์ฃผ์ ์ ์
๋ฐ์ดํฐ๊ฐ ๋ถ์กฑํ์ฌ ์ฃผ์ ์ ์๋ฅผ ํ์ธํ ์ ์์ต๋๋ค.
PolyPid Ltd ๋ด์ค
๋ ๋ง์ ๋ด์ค๊ฐ ๊ณง ์
๋ฐ์ดํธ๋ฉ๋๋ค. ๊ณ์ ์ง์ผ๋ด ์ฃผ์ธ์โฆ
์ฌ๋ฌด ์งํ๎
EPS
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ด ์์ต
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
PolyPid Ltd ์ ๋ณด๎
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
์ข
๋ชฉ ์ฝ๋ PYPD
ํ์ฌPolyPid Ltd
CEOAkselbrad (Dikla Czaczkes)
์น์ฌ์ดํธhttps://www.polypid.com
๊ด๋ จ ์ํ
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%์ธ๊ธฐ ์ฌ๋ณผ
278.120
+2.210ย (+0.80%)
185.410
+13.530ย (+7.87%)
70168.050
+197.920ย (+0.28%)
282.580
+22.390ย (+8.61%)
2083.390
+31.660ย (+1.54%)
411.110
+13.900ย (+3.50%)
4952.980
+142.360ย (+2.96%)
63.303
+0.206ย (+0.33%)
1.182
+0.004ย (+0.35%)
157.098
+0.057ย (+0.04%)
